Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare
Amneal Pharmaceuticals Inc. Operating Income 2016–2025
Amneal Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Amneal Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was 141.8 M, a 41.28% increase year-over-year.
- Amneal Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 423.8 M, a 70.09% increase year-over-year.
- Amneal Pharmaceuticals Inc. annual operating income for 2025 was 394.1 M, a 58.06% increase from 2024.
- Amneal Pharmaceuticals Inc. annual operating income for 2024 was 249.3 M, a 21.99% increase from 2023.
- Amneal Pharmaceuticals Inc. annual operating income for 2023 was 204.4 M, a 315.29% decrease from 2022.
- Amneal Pharmaceuticals Inc. annual operating income for 2022 was -94.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amneal Pharmaceuticals Inc. Operating Income — FAQ
Amneal Pharmaceuticals Inc. (AMRX) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Amneal Pharmaceuticals Inc.'s operating income?
Amneal Pharmaceuticals Inc. (AMRX) reported operating income of $394M for fiscal 2025.
Where can I see AMRX's operating income history?
The chart and table above show Amneal Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.